INVAInnoviva, Inc.

$1B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$70M+59.4% YoY

Gross Profit

$69M99.5% margin

Operating Income

$66M95.5% margin

Net Income

$58M84.0% margin

EPS (Diluted)

$0.50

QoQ Revenue Growth

+42.9%

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$48M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$367M

Total Liabilities

$610M

Stockholders' Equity

-$243M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$44M	+59.4%
Gross Profit	$69M	$43M	+59.9%
Operating Income	$66M	$38M	+76.3%
Net Income	$58M	$25M	+129.2%

INVA Q4 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena